US EditionWeight loss jab Wegovy sales soar in UK as Mounjaro triples in price - Liverpool Echo
Wegovy sales in the UK rose by 2,660% after Mounjaro's 170% price increase, reflecting new users and existing patients switching treatments, health service access remains unchanged.
- Sales of Wegovy in the UK have surged after the maker of rival Mounjaro announced a price increase, with CheqUp reporting strong consumer interest in switching or starting Wegovy treatments.
- Eli Lilly last week announced Mounjaro's highest dose price will rise 170%, from £122 to £330 from September to align with European markets amid political pressure.
- On Wednesday the sales spike equated to a 27-fold increase in Wegovy sales, with the lowest dose costing 85 and highest dose 160 per month, amid over a million estimated users in the UK.
- The NHS will not pay the higher Mounjaro price, ensuring continued access for people with obesity and type 2 diabetes; Toby Nicol, chief executive of CheqUp, said last week demand has surpassed expectations with Wegovy set to become the UK's most popular weight-loss treatment.
- Mounjaro and Wegovy are both weekly injections with different active ingredients; CheqUp noted extraordinary growth across every Wegovy dose, showing both switches and new starters reshaping demand.
26 Articles
26 Articles
The cost of Mounjaro is trebling – but don’t abandon fat jabs until you read this
The monthly cost of a private prescription for Mounjaro is set to exceed £300 from next month – worrying news for the half a million Brits already using weight-loss jabs. Here, doctor and epidemiologist Tim Spector assesses your options if you can no longer afford the medication
'I've lost four stone from Mounjaro - price hike will push 100s to black market'
A woman who has lost four stone in just six months thanks to weight loss jabs has warned that the new drug price hike could push hundreds of people into accessing them on the black market.Vivienne Joy, 52, runs an online community of more than 250 Mounjaro users and is worried the increase in cost might push more people to turn to less reputable sources to acquire the jabs.Her comments come a week after Eli Lilly, which manufactures Mounjaro, an…
Warrington Guardian
Wegovy sales spike after maker of rival Mounjaro ramps up UK price
CheqUp said it had experienced a spike in interest from consumers wanting to switch or begin taking the medication.
Coverage Details
Bias Distribution
- 83% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
